Log In
Print
BCIQ
Print
Print this Print this
 

doxylamine/pyridoxine (Diclectin, Diclegis)

  Manage Alerts
Collapse Summary General Information
Company Duchesnay Inc.
DescriptionDelayed-release tablet containing 10 mg doxylamine and 10 mg pyridoxine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationEmesis
Indication DetailsManage pregnancy-induced nausea and vomiting
Regulatory Designation

Partner

Tzamal Medical Group Ltd.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today